Search results for "From ACP Internist Weekly"
Racial, economic disparities found in use of SGLT2 inhibitors
Although use of sodium-glucose cotransporter-2 (SGLT2) inhibitors rose overall between 2015 and 2019, patients who were Black, Asian, female, or with lower household income had lower rates of prescriptions for the drug class than others with type 2 diabetes.
https://diabetes.acponline.org/archives/2021/05/14/8.htm
14 May 2021
Exercise tips for type 1 diabetes offered by consensus statement
The consensus statement advises physicians about ways to manage people with type 1 diabetes who exercise regularly, including glucose targets for safe and effective exercise and nutritional and insulin dose adjustments to protect against exercise-related glucose excursions.
https://diabetes.acponline.org/archives/2017/02/10/8.htm
10 Feb 2017
Physicians may overtreat blood pressure, glucose in older patients with diabetes
A retrospective cohort study used data from the Department of Veterans Affairs to assess both hypertension and blood glucose medication deintensification (i.e., dosage reduction or withdrawal of a drug).
https://diabetes.acponline.org/archives/2015/11/13/7.htm
13 Nov 2015
Analysis finds several treatments for painful diabetic neuropathy more effective than placebo
A large meta-analysis recently compared the effectiveness of pharmacological treatments for painful diabetic neuropathy.
https://diabetes.acponline.org/archives/2014/11/14/5.htm
14 Nov 2014
GLP-1 agonist plus basal insulin beat other diabetes treatment regimens in meta-analysis
Patients on combination treatment with a glucagon-like peptide-1 receptor (GLP-1) agonist and basal insulin had better HbA1c values, less weight gain, and similar hypoglycemia rates compared to patients on other type 2 diabetes treatment regimens, a recent analysis of previous trials found.
https://diabetes.acponline.org/archives/2014/10/10/6.htm
10 Oct 2014
Nearly 50% of older U.S. adults reported taking aspirin preventively
A study of National Health and Nutrition Examination Survey data from 2011 to 2018 found that 46.7% of respondents ages 60 years and older used aspirin for primary or secondary cardiovascular disease prevention and suggested potential overuse in certain groups.
https://diabetes.acponline.org/archives/2021/07/09/7.htm
9 Jul 2021
Task Force releases systematic review about diabetes screening
A systematic evidence review by the U.S. Preventive Services Task Force suggests that screening asymptomatic adults for elevated glucose levels could help delay progression to diabetes but has not been shown to improve mortality rates.
https://diabetes.acponline.org/archives/2015/06/12/6.htm
12 Jun 2015
Regular use of PPIs linked to increased risk of type 2 diabetes
In an analysis of the Nurses' Health and Health Professionals studies, regular users of proton-pump inhibitors (PPIs) had a 24% higher risk of diabetes than nonusers, with longer duration of use associated with greater risk.
https://diabetes.acponline.org/archives/2020/10/09/9.htm
9 Oct 2020
Group-based lifestyle intervention reduced risk of type 2 diabetes
Participants in the Norfolk Diabetes Prevention Study who underwent multiple educational group sessions that included 50-minute sessions of supervised physical activity had significantly lower odds of type 2 diabetes during a mean follow-up of two years compared to those who received usual care.
https://diabetes.acponline.org/archives/2020/11/13/9.htm
13 Nov 2020
No clear-cut choice among once-weekly GLP-1 receptor agonists
All once-weekly GLP-1 receptor agonists reduced HbA1c and fasting plasma glucose levels, and either no differences or clinically marginal differences were found among the drugs for blood pressure, blood lipid levels, and C-reactive protein levels, according to the systematic review and network meta-analysis.
https://diabetes.acponline.org/archives/2015/12/11/6.htm
11 Dec 2015